Quinoline-4-carboxylic acid 2-oxidoreductase
RxNorm 70317
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 70317 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Quinoline-4-carboxylic acid 2-oxidoreductase.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PT
Designated preferred name (PT):
Quinaldate 4-oxidoreductase
(Atom ID: 611313)
FN
Full form of descriptor (FN):
Quinaldate 4-oxidoreductase (substance)
(Atom ID: 611314)
SY
Synonym (SY):
Quinaldic acid 4-oxidoreductase
(Atom ID: 611306)
PT
Designated preferred name (PT):
Quinoline-4-carboxylate 2-oxidoreductase
(Atom ID: 611311)
FN
Full form of descriptor (FN):
Quinoline-4-carboxylate 2-oxidoreductase (substance)
(Atom ID: 611312)
SY